If your plan does cover Ozempic but the cost-sharing is unmanageable, the Medicare Extra Help program also called the Low Income Subsidy (LIS) can dramatically reduce what you pay for Part D drugs, including GLP-1 medications
Tirzepatide produced the most startling results
As the demand for innovative, effective treatments for diabetes and obesity continues to rise, the GLP-1 market is expected to expand further, with new drug approvals and improved treatment options likely to drive continued success
Heres how these medication options compare across both platforms: Disclaimer: Medication availability depends on a licensed clinicians evaluation and prescription
Hocking SL, Scott DA, Remedios ML, et al
According to recent surveys from late 2025, approximately 12 percent of American adults have used GLP-1 medications such as Ozempic or Wegovy